Aortic valve stenosis

2 trials 1 recruiting MedDRA PT
2 Registered trials
1 Recruiting
2 Unique sponsors
1 Unique IMPs
1 Commercial trials
Drug classes (ATC)
— ATC code not specified 2
Mechanism of action (INN-stem analysis)
Unknown / small molecule 1 substance
Phase III: 1 Phase II: 1

Filter these 2 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 2 trials

Phase III

1 trial
  • Oslo University Hospital HF Academic
    IMP not specified
    2023-510211-20-00 1 country 2021 n=360
    Ended

Phase II

1 trial
  • Novartis Pharma AG Commercial
    PELACARSEN
    2022-502135-19-00 10 countries 2024 n=234
    Recruiting
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Novartis Pharma AG Commercial 1 Phase II 1
Oslo University Hospital HF Academic 1 Phase III 0
New trials by year
2021
1
2024
1
← All indication landscapes